Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Tabuk Pharmaceuticals Signs a Commercial Agreement with Renapharma AB
Monday, March 05, 2018Tabuk Pharmaceuticals Manufacturing Company one of the leading pharmaceutical companies in the Middle East and North Africa region has entered into an exclusive agreement with Renapharma AB on Cholecalciferol Vitamin D dropDetremin Renapharma is a le...
Endo Obtains Preliminary Injunction Against QuVa Pharma, Inc. Preventing Marketing and Release of Vasopressin Product
Friday, March 02, 2018Endo International plc announced that its subsidiaries Par Pharmaceutical Inc and Par Sterile Products LLC Par have obtained a preliminary injunction preventing QuVa Pharma Inc QuVa from marketing and releasing its planned vasopressin product that wo...
Aratana Therapeutics Expands Therapeutic Candidate Pipeline
Friday, March 02, 2018Aratana Therapeutics Inc a pet therapeutics company focused on the licensing development and commercialization of innovative therapeutics for dogs and cats today announced an animal health research and development collaboration with AskAt Inc includi...
Concert Pharmaceuticals Announces Advancement of Novel Drug Candidate in Schizophrenia
Thursday, March 01, 2018Concert Pharmaceuticals Inc announced the next development candidate in its product pipeline with the selection of CTP a novel drug for adjunctive treatment of schizophrenia a devastating chronic illness with significant unmet need CTP is a deuterate...
Covance Enters into Strategic Technology Agreement with GSK
Thursday, March 01, 2018LabCorp a leading global life sciences company announced today that its Covance Drug Development Covance business has entered into a strategic technology agreement with GlaxoSmithKline plc GSK Under the terms of the agreement GSK will use Covances Xc...
Chugai's HEMLIBRA® Approved by European Commission in Hemophilia A with Inhibitors
Wednesday, February 28, 2018Chugai Pharmaceutical Co Ltd announced that Roche has received regulatory approval from the European Commission for HEMLIBRA emicizumab for routine prophylaxis of bleeding episodes in people with hemophilia A with factor VIII inhibitors Following...
Valeant Announces Licensing Agreement With Kaken Pharmaceutical Co., Ltd.
Wednesday, February 28, 2018Valeant Pharmaceuticals International Inc today announced its subsidiary has entered into an exclusive license agreement with Kaken Pharmaceutical Co Ltd Kaken to develop and commercialize products containing a new chemical entity KP which is an inve...
Lantern Pharma Joins Genomics England to Advance Their Precision Oncology Platform
Tuesday, February 27, 2018Genomics England and Lantern Pharma a clinical stage pharma company specializing in precision oncology using artificial intelligence announced today that Lantern will join Genomics Englands Discovery Forum industry partnership The partnership aims to...
Xencor Signs Four Commercial License Agreements with Selexis SA
Tuesday, February 27, 2018Selexis SA a pioneering life sciences company and a global leader in mammalian cell line generation technology today announced that it has signed four commercial license agreements CLAs with Xencor Inc NASDAQ XNCR a clinicalstage biopharmaceutical co...
Kazia Receives FDA Orphan Designation for GDC-0084
Monday, February 26, 2018Kazia Therapeutics Limited an Australian oncologyfocused biotechnology company is pleased to announce that the United States Food and Drug Administration FDA has granted Orphan Drug Designation ODD to Kazias investigational new drug GDC for the treat...
